Genus Plc Ord 10P is listed on the London Stock Exchange trading with ticker code GNS.L, and is part of the Medicine and Biotech Research sector. It has a market capitalisation of £151,169m, with approximately 65m shares in issue. Over the last year, Genus Plc share price has been traded in a range of 908, hitting a high of 2,998.00, and a low of 2,090.00.
Genus Plc, officially known as Genus Plc Ord 10P was formed in September of 1994, making the company twenty five years old. The company filed its latest accounts on 30th June 2014, showing a turnover of approximately 372.20 million GBX, and a pre-tax profit margin of 10.26%. Genus Plc currently has 7 directors, and has had 22 previous directors over the last 25 years. In the last set of accounts produced by Deloitte Llp, the company showed 99.40 million paid in salaries to the 2,314 staff (average wage of 43 thousand), with the directors receiving an average 250 thousand each. In the accounts filed in 2014, the company paid 10100000 in dividends, or 0.1553 per share. These accounts also showed Genus Plc to have a net worth of 150.40 million, with 22.80 million held in cash.
Genus Plc is in the Medicine and Biotech Research sector.
|Electrocomponents Plc (ECM.L)|
|Jpmorgan Emerging Markets Investment Trust Plc (JMG.L)|
|Serco Group Plc (SRP.L)|
|Abcam Plc (ABC.L)|
|Hutchison China Meditech Limited (HCM.L)|
|Shares in Issue||65m|
|52 Week High||2,998.00|
|52 Week Low||2,090.00|